Page last updated: 2024-11-05

sulfonyl chloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID24648
CHEMBL ID3186735
CHEBI ID29291
MeSH IDM0129398

Synonyms (58)

Synonym
sulfuroyl dichloride
sulfonyl dichloride
so2cl2
[scl2o2]
sulfur dichloride dioxide
CHEBI:29291 ,
sulphuryl dichloride
7791-25-5
scl2o2
dichloridodioxidosulfur
sulfuric oxychloride
sulfurylchlorid
sulfonyl chloride
sulfuryl chloride
sulfuryl dichloride
sulfuric dichloride
sulfuryl chloride (so2cl2)
hsdb 827
sulphuryl chloride
sulfur oxychloride (so2cl2)
un1834
epa pesticide chemical code 078002
caswell no. 816
einecs 232-245-6
sulfuryl chloride, 97%
NCGC00248654-01
sulfuryl chloride [un1834] [corrosive]
unii-jd26k0r3j1
jd26k0r3j1 ,
ec 232-245-6
cas-7791-25-5
dtxcid109707
tox21_200484
dtxsid6029707 ,
NCGC00258038-01
sulfuric chloride
FT-0689519
AKOS015856722
sulfuryl chloride [mi]
sulfuryl chloride [hsdb]
YBBRCQOCSYXUOC-UHFFFAOYSA-N
sulfonly chloride
chlorosulfone
chlorosulfonyl chloride
sulphuryichloride
sulfonylchloride
sulfurylchoride
dichlorosulfone
sulphonylchloride
sulphurylchloride
sulphonyl chloride
chlorosulphone
CHEMBL3186735
mfcd00011451
sulfuryl chloride, saj first grade, >=90.0%
Q409926
sulfuryl chloride solutio
AMY27828

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" This method was successfully applied to the analysis of the three drugs in rat plasma and their pharmacokinetic studies."( Pharmacokinetic study of three cardiovascular drugs by high-performance liquid chromatography using pre-column derivatization with 9,10-anthraquinone-2-sulfonyl chloride.
Cui, S; Feng, F; Liu, H; Ma, M; Xie, D; Xu, S, 2007
)
0.54
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
sulfuryl halide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency0.20900.000714.592883.7951AID1259369
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (71)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (14.08)18.7374
1990's4 (5.63)18.2507
2000's21 (29.58)29.6817
2010's31 (43.66)24.3611
2020's5 (7.04)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 66.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index66.24 (24.57)
Research Supply Index4.32 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index109.68 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (66.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.35%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other73 (98.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]